Tata Consultancy Services (TCS) (BSE: 532540, NSE: TCS) has been recognized as a Leader in the IDC MarketScape for Life Science Sales and Marketing Strategic Consulting Services.
According to the report, "TCS has demonstrated a strong investment in the life science sales and marketing space enabled by its IP-based digital solution and products." It further said that "Within life science sales and marketing strategic consulting services, TCS has demonstrated multiple engagements in digital experience management, negotiation strategy, CRM, sales force automation, analytics, infrastructure outsourcing, KOL, physician targeting, incentive and compensation management, e-learning and training, digital asset management, system validation, aggregate spend compliance, e-marketing sites, collaboration services, and others."
"With our deep domain knowledge and comprehensive suite of mar-tech solutions and services, we are helping life sciences customers harness the power of digital technology to simplify and manage their sales and marketing initiatives, improve their overall market intelligence to drive business growth," said Vikas Jain, Global Head, Life Sciences and Healthcare, Enterprise Growth Group, TCS. "This recognition is a testament to our strong vision, innovative efforts, effective strategies, and capabilities that enable superior business outcomes for our customers."
TCS provides a full set of advisory and IT services and solutions across the life sciences value chain, including data and analytics, predictive and prescriptive analytics, genomics research, blockchain enabled clinical supply chain, AI enabled case processing, discovery collaboration, cognitive research, and digital labs. These solutions use a combination of cognitive computing capabilities, artificial intelligence, Internet of Things, robotic process automation and cloud to fully digitalize the life sciences value chain.
TCS has a strong track record of delivering innovative and effective sales and marketing services and strategic consulting services to life sciences companies. Offerings span communication and collaboration, metaverse, Real World Evidence (RWE), as well as data and analytics. The company leverages its deep expertise in digital technologies and data analytics as well as its industry knowledge, to help life sciences companies improve their sales and marketing effectiveness. Additionally, TCS heavily invests in research, innovation and collaborates to help customer accelerate their digital transformation journeys.
"TCS is innovatively addressing customer challenges and helping them remain ahead of the curve. TCS' strong investments in the life sciences sales and marketing space has positioned the company as a Leader," Michael Townsend, Research Director, Life Sciences Commercial Strategies, IDC.
Shares of Tata Consultancy Services Limited was last trading in BSE at Rs. 3257.00 as compared to the previous close of Rs. 3253.15. The total number of shares traded during the day was 20043 in over 2159 trades.
The stock hit an intraday high of Rs. 3283.90 and intraday low of 3250.75. The net turnover during the day was Rs. 65483727.00.